Home » Zelnorm to Be Made Available to U.S. Patients Under Restricted Access Program
Zelnorm to Be Made Available to U.S. Patients Under Restricted Access Program
In cooperation with the U.S. Food and Drug Administration (FDA), Novartis has established a restricted access program for Zelnorm (tegaserod maleate) so that patients in need of this medicine can be considered for treatment.
CNN Money
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May